200 related articles for article (PubMed ID: 15371879)
1. Prostate cancer detection on urinalysis for alpha methylacyl coenzyme a racemase protein.
Rogers CG; Yan G; Zha S; Gonzalgo ML; Isaacs WB; Luo J; De Marzo AM; Nelson WG; Pavlovich CP
J Urol; 2004 Oct; 172(4 Pt 1):1501-3. PubMed ID: 15371879
[TBL] [Abstract][Full Text] [Related]
2. Prostate Cancer Diagnosis Using Urine Sediment Analysis-Based α-Methylacyl-CoA Racemase Score: A Single-Center Experience.
Ji J; Chen X; Xu Y; Cao Z; Xu H; Kong C; Wang F; Sun Y
Cancer Control; 2019; 26(1):1073274819887697. PubMed ID: 31793344
[TBL] [Abstract][Full Text] [Related]
3. Prostate cancer detection by GSTP1 methylation analysis of postbiopsy urine specimens.
Gonzalgo ML; Pavlovich CP; Lee SM; Nelson WG
Clin Cancer Res; 2003 Jul; 9(7):2673-7. PubMed ID: 12855646
[TBL] [Abstract][Full Text] [Related]
4. A duplex quantitative polymerase chain reaction assay based on quantification of alpha-methylacyl-CoA racemase transcripts and prostate cancer antigen 3 in urine sediments improved diagnostic accuracy for prostate cancer.
Ouyang B; Bracken B; Burke B; Chung E; Liang J; Ho SM
J Urol; 2009 Jun; 181(6):2508-13; discussion 2513-4. PubMed ID: 19371911
[TBL] [Abstract][Full Text] [Related]
5. Detection of alpha-methylacyl-coenzyme-A racemase transcripts in blood and urine samples of prostate cancer patients.
Zehentner BK; Secrist H; Zhang X; Hayes DC; Ostenson R; Goodman G; Xu J; Kiviat M; Kiviat N; Persing DH; Houghton RL
Mol Diagn Ther; 2006; 10(6):397-403. PubMed ID: 17154657
[TBL] [Abstract][Full Text] [Related]
6. Application of alpha-methylacyl coenzyme A racemase immunohistochemistry in the diagnosis of prostate cancer: a review.
Adley BP; Yang XJ
Anal Quant Cytol Histol; 2006 Feb; 28(1):1-13. PubMed ID: 16566275
[TBL] [Abstract][Full Text] [Related]
7. alpha-Methylacyl coenzyme A racemase as a tissue biomarker for prostate cancer.
Rubin MA; Zhou M; Dhanasekaran SM; Varambally S; Barrette TR; Sanda MG; Pienta KJ; Ghosh D; Chinnaiyan AM
JAMA; 2002 Apr; 287(13):1662-70. PubMed ID: 11926890
[TBL] [Abstract][Full Text] [Related]
8. Foamy gland carcinoma of the prostate in needle biopsy: incidence, Gleason grade, and comparative α-methylacyl-CoA racemase vs. ERG expression.
Warrick JI; Humphrey PA
Am J Surg Pathol; 2013 Nov; 37(11):1709-14. PubMed ID: 23797726
[TBL] [Abstract][Full Text] [Related]
9. Method for quantification of a prostate cancer biomarker in urine without sample preparation.
Maraldo D; Garcia FU; Mutharasan R
Anal Chem; 2007 Oct; 79(20):7683-90. PubMed ID: 17867650
[TBL] [Abstract][Full Text] [Related]
10. Alpha-methylacyl-CoA racemase and hepsin as urinary prostate cancer markers.
Sroka WD; Adamowski M; Słupski P; Siódmiak J; Jarzemski P; Odrowąż-Sypniewska G; Marszałł MP
Int J Biol Markers; 2015 Nov; 30(4):e401-6. PubMed ID: 25982684
[TBL] [Abstract][Full Text] [Related]
11. Netrin 1 and Alpha-Methyl Acylcoenzim-A Racemase in diagnosis of prostate cancer.
Koseoglu E; Tuncel A; Balci M; Kaya O; Aslan Y; Guzel O; Yilmaz FM; Atan A
Colomb Med (Cali); 2018 Jun; 49(2):164-168. PubMed ID: 30104809
[TBL] [Abstract][Full Text] [Related]
12. A novel diagnostic test for prostate cancer emerges from the determination of alpha-methylacyl-coenzyme a racemase in prostatic secretions.
Zielie PJ; Mobley JA; Ebb RG; Jiang Z; Blute RD; Ho SM
J Urol; 2004 Sep; 172(3):1130-3. PubMed ID: 15311056
[TBL] [Abstract][Full Text] [Related]
13. Alpha-methylacyl-CoA racemase (AMACR) expression in normal prostatic glands and high-grade prostatic intraepithelial neoplasia (HGPIN): association with diagnosis of prostate cancer.
Ananthanarayanan V; Deaton RJ; Yang XJ; Pins MR; Gann PH
Prostate; 2005 Jun; 63(4):341-6. PubMed ID: 15602744
[TBL] [Abstract][Full Text] [Related]
14. Utility of ERG versus AMACR expression in diagnosis of minimal adenocarcinoma of the prostate in needle biopsy tissue.
Andrews C; Humphrey PA
Am J Surg Pathol; 2014 Jul; 38(7):1007-12. PubMed ID: 24705308
[TBL] [Abstract][Full Text] [Related]
15. Detection of alpha-methylacyl-coenzyme A racemase in postradiation prostatic adenocarcinoma.
Yang XJ; Laven B; Tretiakova M; Blute RD; Woda BA; Steinberg GD; Jiang Z
Urology; 2003 Aug; 62(2):282-6. PubMed ID: 12893336
[TBL] [Abstract][Full Text] [Related]
16. Alpha methylacyl-CoA racemase (AMACR) in prostate adenocarcinomas from Japanese patients: is AMACR a "race"-dependent marker?
Yamada H; Tsuzuki T; Maeda N; Yamauchi Y; Yoshida S; Ishida R; Nishikimi T; Yokoi K; Kobayashi H
Prostate; 2013 Jan; 73(1):54-9. PubMed ID: 22593005
[TBL] [Abstract][Full Text] [Related]
17. uPM3, a new molecular urine test for the detection of prostate cancer.
Fradet Y; Saad F; Aprikian A; Dessureault J; Elhilali M; Trudel C; Mâsse B; Piché L; Chypre C
Urology; 2004 Aug; 64(2):311-5; discussion 315-6. PubMed ID: 15302485
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of role of alpha-methyl acyl-coenzyme A racemase/P504S and high molecular weight cytokeratin in diagnosing prostatic lesions.
Jain D; Gupta S; Marwah N; Kalra R; Gupta V; Gill M; Jain N; Lal S; Sen R
J Cancer Res Ther; 2017; 13(1):21-25. PubMed ID: 28508828
[TBL] [Abstract][Full Text] [Related]
19. Utility of immunohistochemistry for alpha-methylacyl-CoA racemase in distinguishing atrophic prostate cancer from benign atrophy.
Farinola MA; Epstein JI
Hum Pathol; 2004 Oct; 35(10):1272-8. PubMed ID: 15492996
[TBL] [Abstract][Full Text] [Related]
20. Semen AMACR protein as a novel method for detecting prostate cancer.
Etheridge T; Straus J; Ritter MA; Jarrard DF; Huang W
Urol Oncol; 2018 Dec; 36(12):532.e1-532.e7. PubMed ID: 30337219
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
